Review: Haloperidol, fluphenazine, clozapine show poor results on cognition
A systematic review and network meta‐analysis encompassing 68 randomized trials has concluded that the antipsychotics haloperidol, fluphenazine, and clozapine ranked lowest on measures of cognition in patients with schizophrenia and related disorders. There were few clear differences overall among the antipsychotics studied, the investigators reported. Results were published online Oct. 16, 2024, in JAMA Psychiatry .
Publication Details
- Journal
- The Brown University Psychopharmacology Update
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1002/pu.31261
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00